Skip to main content
Equibles

PERCEPTIVE ADVISORS LLC

Position in PALI — Palisade Bio, Inc.

CIK 1224962 NEW YORK, NY
Back to PALI Full portfolio

Position in PALI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,608,385
+$1,984,125 QoQ
Shares Held
8,425,065
-5.6% QoQ
Ownership
4.83%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#7
of 124 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PALI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PERCEPTIVE ADVISORS LLC holds $5,490,398,452 across 69 Biotechnology names. PALI ranks #45 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PRAX
Praxis Precision Medicines, Inc.
 2,035,986 $681,627,752
2 SYRE
Spyre Therapeutics, Inc.
 4,319,496 $383,484,854
3 CELC
Celcuity Inc.
 3,197,200 $334,491,064
4 ASND
Ascendis Pharma A/S
 1,163,721 $310,387,665
5 RYTM
Rhythm Pharmaceuticals, Inc.
 2,586,295 $287,156,333
6 ROIV
Roivant Sciences Ltd.
 8,085,461 $286,144,464
7 RLAY
Relay Therapeutics, Inc.
 14,106,187 $263,926,758
8 TVTX
Travere Therapeutics, Inc.
 3,752,574 $213,183,728

All Filings in PALI

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,608,385 8,425,065
2026-03-31 $15,624,260 8,928,149
2025-12-31 $28,317,500 12,050,000